Immix Biopharma Announces 16th Patient Dosing in Ongoing Phase 1b/2a IMX ... - Yahoo Finance

Retrieved on: 2022-12-20 23:32:18

Tags for this article:

Health

Articles

Communication

Forward-looking statement

IMX

Dose

Food and Drug Administration

Clinical trial

Immix Biopharma Inc.

Click the tags to see associated articles and topics

Immix Biopharma Announces 16th Patient Dosing in Ongoing Phase 1b/2a IMX ... - Yahoo Finance. View article details on hiswai:

Excerpt

LOS ANGELES, CA, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”), a biopharmaceutical ...

Article found on: www.yahoo.com

View Original Article